Skip to content

    Navin Fluorine International Q3 FY25 earnings call

    NAVINFLUORGood
    Chemicals·30 Jan 2025
    Management Summary

    Navin Fluorine delivered a strong recovery in Q3 FY25, characterized by significant margin expansion and the commissioning of its large-scale agro specialty plant. The company successfully navigated previous pricing headwinds by optimizing product mixes and increasing capacity utilization across all verticals. Management expressed high confidence in reaching a sustainable 25% EBITDA margin exit rate for FY25 while progressing on several major capex projects including AHF and cGMP4.

    Highlights

    7

    • Quarterly revenue surpassed the ₹600 crore run rate for the first time, reaching ₹606 crores (+21% YoY).

    • Operating EBITDA grew 95% YoY to ₹147 crores, with margins expanding significantly to 24.3% from 15.1% YoY.

    • Successfully commissioned the ₹540 crore agro specialty plant (Project Nectar) at Dahej; commercial dispatches have commenced.

    • High Performance Products (HPP) revenue rose 22% YoY to ₹306 crores, driven by volume growth in HFO, R22, and R32.

    • Specialty Chemicals segment grew 26% YoY to ₹221 crores due to higher capacity utilization at Dahej and Surat.

    • CDMO business reported ₹79 crores revenue (+8% YoY) with a scale-up order received from a major U.S. customer.

    • Net debt-to-equity remains comfortable at 0.41x with net working capital at 99 days of sales.

    Key financials

    Single quarter

    05 metrics
    1. 01Revenue₹606 Cr+21%YoY
    2. 02Operating EBITDA₹147 Cr+95%YoY
    3. 03EBITDA Margin24.3%
    4. 04Profit After Tax₹84 Cr
    5. 05Net Debt to Equity0.41 ratio

    Segment breakdown

    • High Performance Products (HPP)₹306 Cr50.5%
    • Specialty Chemicals₹221 Cr36.5%
    • CDMO₹79 Cr13.0%
    Donut· Share of Revenue

    Guidance & targets

    5
    CategoryTargetPriority
    Margin
    EBITDA Margin Exit Rate
    25%
    		High
    Revenue
    Project Nectar Peak Annual Revenue
    ₹515 crores
    		High
    Capacity
    R32 Capacity Expansion
    4,500 MT
    		High
    Capex
    AHF Project Commissioning
    ₹450 crores
    		High
    Capex
    cGMP4 Phase 1 Commissioning
    ₹160 crores
    		High

    Risks & concerns

    5
    RiskSeverity

    Agrochemical Sector Pricing Pressure

    Management admitted to near-term pricing pressure in the ag-chem sector but is navigating it by securing higher volumes and launching new molecules. — Management acknowledged

    medium

    Fluorspar Supply Sustainability

    Analysts raised concerns about depleting Chinese fluorspar reserves; management countered that they have multiple long-term contracts and a flexible plant design that can use ore from Mexico, Africa, and SE Asia. — Analyst downplayed

    low

    Complex Chemistry Execution Risks

    The Nectar project involves high-temperature chlorination and extreme freezing, requiring a slow and disciplined ramp-up to ensure safety. — Management acknowledged

    medium

    Areas of Evasion(2)

    • Specific quantum of orders for CY25 in CDMO
    • Specific technology partners for high-purity AHF for EV batteries

    Q&A highlights

    3

    “It's a very complex chemistry involving high degree of chlorination at high temperatures... we want to ramp this project progressively, but in a safe and reliable manner.”

    Investors were concerned about the yield and operational stability of the new ₹540 crore plant; management confirmed a cautious, phased ramp-up.

    asked by Sanjesh Jain

    2 min read5 chapters

    Detailed Narrative

    01

    Margin Recovery and Operational Efficiency

    Navin Fluorine's EBITDA margin saw a dramatic recovery to 24.3% in Q3 FY25, up from 15.1% in the prior year. This expansion was driven by a combination of operating leverage (contributing ~5%), procurement efficiencies, and improved product mixes (contributing ~4.9%). Management emphasized that these margins are sustainable due to strong order book visibility and a shift toward higher-realization products in the HPP vertical.

    02

    Project Nectar: A Strategic Milestone

    The commissioning of the ₹540 crore agro specialty plant at Dahej marks a major milestone. While dispatches only began in December 2024, the project is expected to reach a peak annual revenue of ₹515 crores by FY27. The ramp-up will be progressive due to the complex chemistry involved, with FY26 expected to reach approximately 40-45% of the peak capacity.

    03

    HPP Vertical Gains Momentum

    The High Performance Products segment grew 22% YoY to ₹306 crores. Growth was supported by volume increases in HFO and refrigerants like R22 and R32. A new R32 capacity of 4,500 MT is set for commissioning in February 2025, and management is already in strategic discussions with global majors for further capacity enhancements, indicating robust global demand.

    04

    CDMO Pipeline and Fermion Update

    The CDMO business is poised for growth with the Fermion registration expected in April/May 2025. Direct dispatches have already started, and the company has secured orders for the full calendar year 2025. Additionally, a scale-up order from a major U.S. customer and the ongoing ₹160 crore cGMP4 expansion (Phase 1) provide a clear runway toward the company's $100 million CDMO revenue aspiration.

    05

    Raw Material Security and AHF Project

    Management addressed concerns regarding fluorspar availability by highlighting their diversified sourcing strategy across Mexico, China, and Africa. The upcoming ₹450 crore AHF project, scheduled for early FY26, is described as a 'license to dream' project that will allow the company to capture more value captive and reduce reliance on merchant sales while improving overall realizations per kg of AHF.

    This is an AI-generated summary of a publicly available earnings call transcript.